Clinical Trial Update: Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment [NA]

View source ↗

Summary

ClinicalTrials.gov entry describing a study of a neoantigen-based peptide vaccine plus conventional second-line therapy for colorectal cancer that progressed af…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Conventional second-line therapy
• Neoantigen-based Peptide Vaccine

Snippet

Sponsor: The First Affiliated Hospital of Nanchang University | Conditions: Colorectal Cancer (CRC) | NA | Status: RECRUITING